The Trump administration is exploring a regulatory approach aimed at compelling drug manufacturers to reduce prices in the United States to levels that align with those...
Australia is taking a significant step towards healthcare inclusivity as an independent committee examines the possibility of Medicare funding for gender-affirming surgeries for transgender adults, specifically...
A federal judge has ordered CVS Health’s pharmacy benefit manager, Caremark, to pay nearly $290 million following allegations of fraud against Medicare related to prescription drug...
Consumers navigating the complexities of Medicare Part D often face significant challenges, particularly regarding prescription drug coverage. Joel Mekler highlights the dual categories of issues that...
